Latest Headlines

  1. Novotech Partners With Kyungpook National University Hospital To Strengthen Clinical Trial Capabilities In South Korea 3/19/2025

    Novotech, a global leading full-service clinical CRO, and Acrostar, a provider of Site Management Organization (SMO) services, have entered into a strategic partnership that will support clinical trials across NHUH’s prestigious institutions including the Advanced Clinical Trials Center, the KNUH main campus, and the Chilgok KNUH in South Korea.

  2. Aseptic Filling System Provider Announces New Chief Commercial Officer 3/17/2025

    AST, a leading provider of flexible aseptic filling systems, is pleased to announce an exciting addition to the Leadership team. Charisse Curtis has joined AST as Chief Commercial Officer, leading the Business Development, Marketing, and Communications teams. 

  3. AST Will Exhibit New ATMP Fill-Finish Production Line At INTERPHEX Conference 2025 3/13/2025

    AST to introduce its fully automatic isolated GENiSYS C in addition to new glove testing and digital twin solutions during the premier global pharmaceutical event at Javits Center, NYC.

  4. Simbec-Orion And Avance Clinical Consolidates Partnership With Memorandum Of Understanding 3/4/2025
  5. Agilitech Biotech Is Now Tezalon Biotech 2/26/2025

    Agilitech, formerly Agilitech Biotech, a name synonymous with innovation and trusted solutions in the biotech industry, is proud to announce its rebrand, marking an exciting evolution in its commitment to delivering comprehensive, tailored solutions to its clients.

  6. Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology For Research Grade Applications 2/18/2025

    Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free DNA technology. This revolutionary technology represents a significant advancement in synthetic DNA manufacturing, offering a cell-free, enzymatic process to generate linear DNA (linDNA) templates for in vitro transcription (IVT) synthesis of mRNA molecules.

  7. Cryoport Express® Cryogenic HV3 Shipping System Expands Patient Access To Biologics And Other Temperature-Sensitive Life Saving Therapies 2/3/2025
  8. Novotech Releases Comprehensive Report On Oncolytic Virus Therapy 1/30/2025

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment. 

  9. Novotech Releases Report On Current State Of Triple-Negative Breast Cancer Clinical Trials 1/30/2025

    Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Triple-Negative Breast Cancer (TNBC). The report highlights significant advancements in therapeutic strategies, regional clinical trial activity, and evolving biomarkers driving innovative TNBC treatments. 

  10. Comparing Eye Exams In Mobile Settings To In-Office Exams 1/29/2025

    2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has completed its observational study to assess the quality of subjective refraction, autorefraction, and keratometry measurements in a mobile eye setting.